First Tracks Biotherapeutics (TRAX) Stock Price, News & Analysis

Company Overview

Key Stats

• Today's Range: $17.68 to $18.63
• 50-Day Range: N/A
• 52-Week Range: $14.79 to $26.80
• Volume: 211,551 shs
• Average Volume: 415,346 shs
• Market Capitalization: $633.64 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $39.43
• Consensus Rating: Buy

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: NASDAQ:TRAX
• CIK: 2091349
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for First Tracks Biotherapeutics: $39.43
• High Price Target: $54.00
• Low Price Target: $30.00
• Potential Upside/Downside: +117.1%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 34,892,000
• Free Float: N/A
• Market Cap: $633.64 million
• Optionable: N/A
• Beta: N/A